¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"over refraction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • over refraction
    µ¡´ï±¼Àý°Ë»ç
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carry-over effect
    ÀÜÈ¿
  • atomic refraction
    ¿øÀÚ±¼Àý
  • cycloplegic refraction
    Á¶Àý¸¶ºñ±¼Àý
  • molecular refraction
    ºÐÀÚ±¼Àý
  • manifest refraction
    Çö¼º±¼Àý°Ë»ç
  • refraction
    1. ±¼Àý 2. ±¼Àý°Ë»ç
  • streaming double refraction
    À¯µ¿º¹±¼Àý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refraction
    ±¼Àý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • over refraction
    µ¡´ï±¼Àý°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carry-over effect
    ÀÜÈ¿
  • crossing-over suppressor
    ±³Â÷¾ïÁ¦ÀÎÀÚ
  • tie-over dressing
    ºÀÇÕ°íÁ¤µå·¹½Ì
  • nerve cross over
    ½Å°æ±³Â÷¼ú
  • atomic refraction
    ¿øÀÚ±¼Àý
  • cycloplegic refraction
    Á¶Àý¸¶ºñ±¼Àý°Ë»ç
  • manifest refraction
    Çö¼º±¼Àý°Ë»ç
  • molecular refraction
    ºÐÀÚ±¼Àý
  • refraction
    ±¼Àý
  • streaming double refraction
    À¯µ¿º¹±¼Àý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • OTC drug : over-the-counter drug
    ÀϹݸžà.
  • angle of refraction
    ±¼Àý°¢.
  • index of refraction
    ±¼Àý·ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • over refraction
    µ¡´ï±¼Àý°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • angle of refraction
    ±¼Àý°¢.
  • atomic refraction
    ¿øÀÚ±¼Àý.
  • cycloplegic refraction
    Á¶Àý¸¶ºñ±¼Àý°Ë»ç(¡­ÏÝï¹ËþÞÛ).
  • index of refraction
    ±¼Àý·ü
  • manifest refraction
    Çö¼º±¼Àý°Ë»ç
  • molecular refraction
    ºÐÀÚ±¼Àý(¡­ÏÝï¹).
  • refraction
    ±¼Àý
  • specific refraction
    ºñ±¼Àý(ÝïÏÝï¹).
  • streaming double refraction
    À¯µ¿º¹±¼Àý(êü ÔÑÜÜÏÝï¹).
  • bed turn over rate
    º´»óȸÀüÀ²
  • carry-over
    ÀÜÈ¿(íÑüù)
  • carry-over effect
    ÀÜÈ¿(íÑüù).
  • cross over value
    ±³Â÷°ª.
  • cross-over
    ±³¹è(ÎßÛÕ), ±³Â÷(Îßó©).
  • crossing over
    À¯ÀüÀÚ±³È¯(ë¶îîí­Îßüµ), ±³Â÷.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crossing over
    "±³Â÷(Îßó©), ±³¹è(ÎßÛÕ)"
  • somatic crossing over
    ü¼¼Æ÷ ±³Â÷(ô÷á¬øàÎßó©)
  • double refraction
    "ÀÌÁß º¹±¼Àý(ì£ñì.ÜÖÏÝï¹), (ÔÒ) birefringence"
  • double refraction of flow
    À¯µ¿º¹±¼Àý(×µÔÑÜÜÏÝï¹) (ÔÒ) flow birefringence
  • index of refraction
    ±¼ÀýÁö¼ö(ÏÝï¹ò¦â¦)
  • refraction
    ±¼Àý(ÏÝï¹)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refraction
    ±¼Àý
  • over extension
    °úµµ¿¬Àå, °ú´Ù½ÅÀü
  • over-estimate
    °ú´ëÃßÁ¤
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PR by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr...
RFR rapid fluid resuscitation; refraction
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
OD   1) Doctor of Optometry
  2) Oculus Dexter; Right Eye; ¿ìÃø´«
  3)...
CO carbon monoxide; cardiac output; castor oil; casualty officer; centric occlusion; cervical orthosis;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EOI Emotional Over-Involvement
NOESY Nuclear Over-hauser enhancement spectroscopy
OTC Over The Counter
ROPS Roll-over protective structures
ROT Roll-over test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • coefficient of refraction
    ±¼Àý °è¼ö
  • refraction
    ±¼Àý
    1. ±¼ÀýÀÇ ÀÛ¿ë ¶Ç´Â °úÁ¤. ƯÈ÷ ´«ÀÇ ±¼Àý ¿ÀÂ÷ÀÇ °áÁ¤°ú ±×°ÍÀÇ ¾È°æ¿¡ ÀÇÇÑ ±³Á¤. 2.ÇϳªÀÇ ¸Åü¿¡¼­ ¹Ðµµ°¡ ´Ù¸¥ º°°³ÀÇ ¸Åü¿¡ ºñ½ºµëÈ÷ ºûÀÌ Åë°úÇÒ ¶§ ºûÀÌ ±¸ºÎ·¯Áö´Â °Í. ÆíÇâÀº 2°³ÀÇ ¸Åü °è¸é¿¡ ÀϾ¸ç, ±¼Àý¸éÀ̶ó°í ¾Ë·ÁÁ® ÀÖ´Ù. ±¼Àý ÀüÀÇ ±¤¼±Àº ÀԻ籤, ±¼Àý ÈÄÀÇ ±¤¼±Àº ±¼Àý±¤ÀÌ´Ù. ÀԻ籤°ú ±¼Àý±¤ÀÇ ±³Â÷Á¡À» ±¼ÀýÁ¡À̶ó°í ÇÑ´Ù. ±¼ÀýÁ¡¿¡¼­ Ç¥¸é¿¡ Á÷°¢À¸·Î ±×Àº ¼±°ú ÀԻ籤°úÀÇ »çÀÌ¿¡ Çü¼ºµÈ °¢À» ÀԻ簢À̶ó°í ºÎ¸£¸ç, ±¼Àý ±¤¼±°úÀÇ »çÀÌÀÇ °¢µµ¸¦ ±¼Àý°¢À̶ó°í ºÎ¸¥´Ù. ÀԻ簢ÀÇ Á¤ÇöÀ» ±¼Àý°¢ÀÇ Á¤ÇöÀ¸·Î ³ª´« °ªÀÌ »ó´ë¼º ±¼Àý·üÀÌ´Ù
  • change over time
    ½Ã°£¿¡ µû¸¥ º¯È­
  • constant turn over
    ÀÏÁ¤ÇÑ È¸Àü
  • cross-over position
    ¹Ý´ëÀ§
  • crossing over
    ±³¹è, ±³Â÷
    Á¦ 1°¨¼öºÐ¿­ÀÇ Å»ç±â Áß¿¡ ½ÖÀ» ÀÌ·ç´Â »óµ¿ ¿°»öüÀÇ ºñÀڸŠ¿°»öºÐü »çÀÌ¿¡¼­ ÀϾ´Â À¯Àü¹°ÀÇ ±³È¯. ±× °á°ú·Î »õ·Î¿î À¯ÀüÀÚÀÇ Á¶ÇÕÀÌ ÀϾ´Ù.
  • over carve
    °úÀ× Á¶°¢
  • over interpretation
    °ú´Ù ÆÇµ¶
  • over work
    °ú·Î
  • slide over
    -À» ó¸®ÇÏ´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
angle of refraction <optics> The angle that a ray leaving a refracting medium makes with a line drawn perpendicular to the surface of this medium.
(05 Mar 2000)
refraction <physics> Bending of waves as they pass from a medium having one refractive index to a medium (or region within a medium) having a different refractive index.
(09 Oct 1997)
refraction, angle of <microscopy> The acute angle between the normal to a refracting surface at the point of incidence, and the refracted ray.
(05 Aug 1998)
refraction, ocular Refraction of light effected by the media of the eye. It also includes the determination of the refractive state and refractive correction.
(12 Dec 1998)
static refraction Refraction without accommodation.
(05 Mar 2000)
double refraction <microscopy> The refraction of light in two slightly different directions to form two rays or vector components. Each ray is polarized, and their vibration directions are perpendicular to each other. Furthermore, each ray has a different velocity, and therefore a different refractive index.
See: birefringence.
(05 Aug 1998)
dynamic refraction Refraction of the eye during accommodation.
(05 Mar 2000)
index of refraction <physics> For a given wavelength, this is the ratio of the velocity of light in vacuum (c) to the velocity of light in a refractive material (for example, glass, plasma, etc.).
(09 Oct 1997)
law of refraction For two given media, the sine of the angle of incidence bears a constant relation to the sine of the angle of refraction.
Synonym: Descartes' law, Snell's law.
(05 Mar 2000)
aged, 80 and over A person 80 years of age and older.
(12 Dec 1998)
maternal age 35 and over Pregnancy in women 35 or more years of age. It is used for normal pregnancies and for problems of pregnancy occurring in a woman's late reproductive years. These include effects on the mother's physical and mental health as well as risks of perinatal mortality and foetal abnormality.
(12 Dec 1998)
crossing over <genetics, molecular biology> The breaking during meiosis of one maternal and one paternal chromosome, the reciprocal exchange of corresponding sections of DNA along pairs of homologous chromosomes by symmetrical breakage and crosswise rejoining of the chromosomes.
This results in the transfer of a block of genes from each chromosome to its homologue. In contrast to genetic recombination, which is a phenotypic phenomenon, crossing-over is genotypic. Any even number of crossing-overs between two loci will cancel out phenotypically and no recombination will occur.
Recombination can result from DNA exchange of alleles between between homologous chromatids in meiosis, giving rise to chiasmata.
Compare: recombination.
(10 Nov 1998)
somatic crossing-over Crossing-over that occurs during the mitosis of somatic cells, in contrast to that which occurs in meiosis.
(05 Mar 2000)
drug, over-the-counter Drug for which a prescription is not needed.
(12 Dec 1998)
tie-over dressing A dressing placed over a skin graft or other sutured wound and tied on by the sutures which have been left of sufficient length for that purpose.
Synonym: bolus dressing.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • over and over again
    µÇÇ®ÀÌÇØ¼­
  • refraction
    ±¼Àý
  • double refraction
    (±¤)º¹±¼Àý
  • refraction
    ±¼Àý(ÀÛ¿ë);±¼»ç;(´«ÀÇ)±¼Àý·Â(ÃøÁ¤);´ë±âÂ÷
  • blow over
    (ÆøÇ³¿ì°¡)ÀÜÀÜÇØÁö´Ù
  • brood over
    °õ°õÈ÷ »ý°¢ÇÏ´Ù
  • call over
    (À̸§À»)Å©°Ô ºÎ¸£´Ù; Á¡È£ÇÏ´Ù
  • carry over
    (±Ý¾×À»)ÀÌ¿ùÇÏ´Ù
  • come over
    (ÀϺη¯)¿À´Ù; º¯ÀýÇÏ´Ù
  • get over
    ±Øº¹ÇÏ´Ù; ¿Ï¼ºÇÏ´Ù; ´©±×·¯Áö´Ù
  • give over
    ³Ñ°ÜÁÖ´Ù; Æ÷±âÇÏ´Ù
  • go over
    (°­ß®¹Ù´ÙµîÀ»)°Ç³Ê´Ù
  • half-seas-over
    ¾ó±ÙÈ÷ ÃëÇÑ
  • hand over
    ³Ñ°ÜÁÖ´Ù
  • hold over
    ¿¬±âÇÏ´Ù; °è¼ÓÇÏ´Ù; Èֵθ£´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á